Select Page
07 Introduction: Welcome to Cancer Control 2022 Ian Magrath, Editor-in-Chief, Cancer Control and President, International Network for Cancer Treatment and Research and Tim Probart, Publisher, Cancer Control and CEO, Global Health Dynamics
08 Special Regional Report: Cancer care in Ukraine – A first-hand account Oleksandr Stakhovskyi, Senior Research Officer, Department of Uro-Oncology, National Cancer Institute, Kyiv, Ukraine
11 Cancer Control 2022 Survey How have the current global difficulties affected your institution’s support for cancer care projects in poorer-resourced settings?
13 Interview: Rifat Atun, Professor of Global Health Systems atHarvard University, USA
19 How strengthening health financing capacities is key to expanding access to cancer medicines in low- and middle-income countries Cary Adams, CEO, Union for International Cancer Control and Andrea Feigl, CEO, Health Finance Institute
23 Rays of Hope: Expanding access to cancer care requires innovative financing models Victor Sapkota, Intern, Resource Mobilization Section, Programme of Action for Cancer Therapy, International Atomic Energy Agency; Becky Lee, Intern, Division of Human Health, International Atomic Energy Agency and Chief Radiation Oncology Resident, Loma Linda University, CA, USA; May Abdel-Wahab, Director, Division of Human Health, International Atomic Energy Agency and Lisa M Stevens, Director, Programme of Action for Cancer Therapy, International Atomic Energy Agency
29 Rethinking the role of the development sector in public-private partnerships (PPPs) for cancer care in low- and middle-income countries Mathieu Morand, Senior Manager, Digital and Health Financing, City Cancer Challenge Foundation; Karine Bachongy, Global Sector Lead, Social Infrastructure PPP, International Finance Corporation; and Ilaria Di Meglio, Content and Communications Manager, City Cancer Challenge Foundation
35 Increasing momentum to reach the Commonwealth cervical cancer elimination targets by 2025 Janneth Mghamba, Health Advisor, Commonwealth Secretariat; Emily Gilmour, Health Research Officer, Commonwealth Secretariat and Layne Robinson, Head of Social Policy Development, Commonwealth Secretariat
39 The SUCCESS Project: Supporting the elimination of cervical cancer through an integrated approach to secondary prevention Lisa Huang, SUCCESS Project Director, Expertise France; Tracey Shissler, Implementation Director, SUCCESS, Jhpiego; Kirstie Graham, Director of Capacity Building, Union for International Cancer Control; and Mélissa Archambault, SUCCESS Project Manager, Expertise France
44 Defining opportunities to improve survival and quality of life for women with ovarian cancer in 24 low- and middle-income countries: The Every Woman StudyTM Frances Reid, Programme Director, World Ovarian Cancer Coalition, UK; Tracey Adams, Specialist in Obstetrics and Gynaecology, Groote Schuur Hospital, Cape Town, South Africa; Anmol Bajwa, Candidate, Masters in Health Policy and Management, Mailman School of Public Health, Columbia University, USA; Phaedra Charlton, Director of Communications and Marketing, World Ovarian Cancer Coalition, Canada; Robin Cohen, CEO and Co-Founder, Sandy Rollman Ovarian Cancer Foundation, USA; Mary Eiken, CEO, International Gynecologic Cancer Society, USA; Clara MacKay, CEO, World Ovarian Cancer Coalition, Canada; Aisha Mustapha, Consultant in Gynaecologic Oncology, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria and Senior Lecturer at the affiliate University; Afrin Shaffi, Student in Gynaecologic Oncology, Moi University/Moi Teaching & Referral Hospital, Kenya and Fellow, International Gynecologic Oncology Society and Woo Yin Ling, Professor of Obstetrics and Gynaecology, University of Malaya and Consultant Gynaecological Oncologist, University Malaya Medical Centre, Malaysia
53 Oral cavity cancer screening and early detection in rural India SB Sutcliffe, Two Worlds Cancer Collaboration Foundation, Kelowna, BC, Canada; SS Broughton, Two Worlds Cancer Collaboration Foundation, Kelowna, BC, Canada and Faculty of Health and Social Development University of British Columbia, Okanagan, Canada; M Datta, Faculty of Dentistry, University of British Columbia, Vancouver, Canada; CSK Chaitanya Nallan, Panineeya Institute of Dental Sciences, Hyderabad, India; NDVN Shyam, Government Dental College, Osmania University, Hyderabad, India; P Kumari, Department of Zoology, Nizam’s College, Hyderabad, India; JJ Mathews, MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad, India and Division of Palliative Medicine, Departments of Medicine and Oncology, Queen’s University, Kingston, Ontario, Canada; SM Wai, Two Worlds Cancer Collaboration Foundation, Kelowna, BC, Canada; JN Jagannath, MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad, India; V Rapelli, MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad, India; S Kumari, MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad, India; G Palat, MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad, India; and DM Laronde, Faculty of Dentistry, University of British Columbia, Vancouver, Canada and Cancer Control Research, BC Cancer, Vancouver, Canada
60 SIOP’s PARC Program: Advancing research capacity for paediatric cancer clinical trials in low- resourced countries Guillermo L Chantada, President, International Society of Paediatric Oncology (SIOP), Head of Outreach Programme, Hospital Sant Joan de Déu, Barcelona, Spain; Tzvetomira Laub, Executive Director for Programmes and Strategy, International Society of Paediatric Oncology (SIOP), Geneva Switzerland; and Kathy Pritchard-Jones, Immediate past-President, International Society of Paediatric Oncology (SIOP) and Professor of Paediatric Oncology at UCL Great Ormond Street Institute of Child Health, University College London, London, UK
67 INCTR Branches
68 Governing CouncilPartner institutions in developing countries:Past and present
69 Partners: Past and present